Lab Reagents for Pathology Dept. at WRNMMC
Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/8e70ea9405c445909580878c1bf0509c/view
Timeline
    Description

    The Defense Health Agency (DHA) intends to award a sole source contract to Roche Diagnostics Corporation for the procurement of specialized lab reagents and consumables necessary for molecular diagnostics testing in the Pathology Department at Walter Reed National Military Medical Center (WRNMMC). This procurement is critical for testing viral pathogens and is supported under the authority for non-competitive purchases, as Roche is the sole supplier of the proprietary materials required for use with the existing Roche medical equipment at WRNMMC. Interested parties may submit their qualifications by January 10, 2025, via email to the primary contact, Ealed Nuru, at ealed.m.nuru.civ@health.mil, with a copy to Erica S. Oh at erica.s.oh.civ@health.mil. The government retains discretion over the contract award process and is not obligated to seek competitive bids despite any expressions of interest received.

    Files
    Title
    Posted
    ROCHE LAB REAGENTS SPECIAL NOTICE.docx
    The Defense Health Agency (DHA) intends to award a sole source contract to Roche Diagnostics Corporation for specialized reagents and consumables necessary for molecular diagnostics testing in the Pathology Department at Walter Reed National Military Medical Center (WRNMMC). The procurement, supported under the authority for non-competitive purchases, is essential for testing viral pathogens. Roche is the only supplier of the proprietary materials required, which must be used with the existing Roche medical equipment at WRNMMC. This notice serves as an intent to contract rather than a request for proposals, and any interested parties may submit their qualifications by January 10, 2025, through specified email addresses. The government retains discretion over the contract award process, indicating no obligation to seek competitive bids despite any expressions of interest received.
    Lifecycle
    Title
    Type
    Lab Reagents for Pathology Dept. at WRNMMC
    Currently viewing
    Special Notice
    Similar Opportunities
    Nova Benchtop System
    Active
    Dept Of Defense
    The Department of Defense, through the United States Army Medical Research Acquisition Activity (USAMRAA), intends to negotiate a sole source contract with Helix Biotech for the acquisition of a Nova Benchtop Microfluidics device. This procurement aims to secure a chip-less, scalable, and highly flexible modular system essential for the encapsulation of mRNA for cellular delivery, including all necessary ancillary components, delivery, self-installation with virtual support, training, and a one-year manufacturer warranty. The device is critical for producing lipid nanoparticles, which play a significant role in various biomedical applications. Interested parties may submit their capability information by 2:00 p.m. Eastern Time on January 16, 2025, to Ms. Natalie Bethel at natalie.l.bethel2.civ@health.mil, as this notice is not a request for competitive quotations.
    Microbial Testing Supplies - Bridge Contract
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    Sources Sought Notice - Cost-Per-Test (CPT) Agreement or Reagent Rental Agreement to include reagents, molecular PCR instrument/equipment, consumables, maintenance support and instrument warranties at BAMC.
    Active
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office West (MRCO), is seeking potential sources for a Cost-Per-Test (CPT) Agreement or Reagent Rental Agreement to support molecular genetic and infectious disease testing at the Brooke Army Medical Center (BAMC) in Fort Cavazos, Texas. The procurement includes the provision of molecular PCR instruments, reagents, consumables, maintenance support, and instrument warranties, with a base performance period from October 1, 2025, to September 30, 2030. This initiative is critical for enhancing the laboratory's capabilities in conducting various genetic tests, including those for Celiac Disease, Alzheimer’s Disease, and a comprehensive Dermatomycosis Panel, which are essential for informed health assessments and treatment decisions. Interested parties are encouraged to submit their capability statements and relevant information to the primary contact, Medina L. Woodson, at medina.l.woodson.civ@health.mil, by the specified deadlines, as this notice is solely for information and planning purposes and does not constitute a solicitation.
    Notice of Intent to Sole Source
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to sole source a Purchase Order to GE Precision Healthcare LLC for the maintenance of Viewpoint Software used in ultrasounds. This procurement is essential as GE Healthcare is the sole manufacturer and authorized government distributor for this specific software maintenance, ensuring the continued functionality of critical medical equipment. The contract will cover a performance period from January 15, 2024, to January 14, 2030, including a base year and four option years. Interested parties who believe they can meet these requirements are encouraged to submit capability statements to Dwayne Casad at Dwayne.M.Casad.civ@health.mil or call 210-868-4977 before the closing date of the notice.
    Special Notice- Intent to Sole Source Award the Purchase of Lab Instruments to Agilent Technologies Inc.
    Active
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Contracting Command – Aberdeen Proving Ground, intends to award a sole source contract to Agilent Technologies Inc. for the purchase of specialized lab instruments, namely the Seahorse XF and xCELLigence systems. These instruments are essential for conducting precise physiological measurements critical to military ration development and ongoing research efforts at the U.S. Army Combat Capabilities Development Command – Soldier Center. The procurement is justified based on the unique capabilities of Agilent's systems, which are not available from other vendors, and is necessary to avoid significant operational setbacks in military research missions. Interested parties may express their interest and capabilities by contacting Edmund J. Bousaleh and Alejandro Ayala via email by 1500 HRS ET on January 14, 2025, with the contract funded through Research, Development, Test, and Evaluation (RDT&E) for fiscal year 2024.
    6550--Notice of Intent to Sole Source - Minneapolis VA Medical Center - FDA-Approved Microgenics DRI Ecstasy Plus Assay Reagent used with Beckman AU480 Analyzers
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to negotiate a sole source contract with Microgenics Corporation for the procurement of FDA-approved Microgenics DRI Ecstasy Plus Assay Reagent, which is essential for use with Beckman AU480 Analyzers at the Minneapolis VA Medical Center. This contract action is being pursued under the authority of FAR 13.106-1, which allows for sole source awards when only one source is available to meet the government's requirements. The reagents are critical for in-vitro diagnostic testing, ensuring accurate and timely results for patient care. Interested vendors who believe they can meet the requirements are invited to submit a capability statement by 12:00 PM Central Time on January 9, 2025, to Alisha Milander at Alisha.Milander@va.gov, with all submissions needing to include registration details in the System for Award Management (SAM).
    REQUEST FOR INFORMATION METABOLOMICS ANALYSIS SERVICES
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking information from qualified vendors for specialized metabolomics analysis services to support ongoing research at the United States Army Medical Research Institute of Environmental Medicine (USARIEM). The procurement aims to obtain both untargeted and targeted metabolomics measurements from various human biological samples, including urine, blood, feces, saliva, and tissue, necessitating advanced laboratory capabilities such as ultra-high performance liquid chromatography-tandem-mass spectrometry (UPLC-MS/MS) and gas chromatography-mass spectrometry (GC-MS). This initiative is critical for enhancing the understanding of metabolic functions and nutritional status within military health studies. Interested parties must submit their qualifications, including business size and capabilities, by January 7, 2025, to Kasey Carroll at kasey.l.carroll.civ@health.mil, as responses are voluntary and will not result in a binding contract.
    6630--Notice of Intent - Sole Source Bridge Contract - Integrated Chemistry CPRR
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source bridge contract to Beckman Coulter, Inc. for an integrated chemistry Cost-Per-Reportable Result (CPRR) program. This procurement includes equipment rental and maintenance services, as well as 103 different chemistry and immunochemistry tests, ensuring the provision of necessary reagents, controls, and consumables for the Central Texas Veterans Health Care System. The contract is crucial for maintaining laboratory operations during the transition to new equipment analyzers, with the anticipated period of performance from January 15, 2025, to October 14, 2025. Interested parties may submit capability statements for consideration within seven days of this notice, after which the contract will be finalized with Beckman Coulter, Inc. if no other responses are received. For further inquiries, contact Kathryn Prose at kathryn.prose@va.gov or (254) 217-2835.
    6640--NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole-source contract to Illumina, Inc. for the provision of molecular testing reagents required by the Minneapolis VA Health Care System. This procurement involves a Firm Fixed Price Purchase Order for a base year plus four option years, specifically for next-generation sequencing reagents that are compatible with the VA's existing Illumina sequencers. The sole-source justification is based on the fact that Illumina is the only authorized supplier for these specialized reagents, with no alternative products approved for use on the VA's equipment. Interested vendors who believe they can meet the requirements are encouraged to submit capability statements by January 10, 2025, to the Contracting Officer, Traci Johannes, at traci.johannes@va.gov.
    INTENT TO SOLE SOURCE TO STRYKER ORTHOPAEDICS GOVT. SALES
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to award a sole source contract to Stryker Orthopaedics Govt. Sales for the maintenance and service of the AIRO Mobile CT Scanner at the Naval Medical Center San Diego. The contract aims to ensure comprehensive equipment management in accordance with the original equipment manufacturer's specifications, including regular maintenance, unscheduled repairs, and a commitment to a 95% uptime rate for the equipment. This service is critical for maintaining operational efficiency in military healthcare operations, ensuring that advanced medical imaging capabilities remain functional and compliant with regulatory standards. Interested parties must submit their capability statements by 10:00 AM Pacific Time on January 9, 2025, via email to dernell.w.wade.civ@health.mil, referencing Special Notice Number HT941025N0024.